Wenjun Zhou

6.6k total citations · 1 hit paper
56 papers, 2.0k citations indexed

About

Wenjun Zhou is a scholar working on Molecular Biology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Wenjun Zhou has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Psychiatry and Mental health and 10 papers in Physiology. Recurrent topics in Wenjun Zhou's work include Dementia and Cognitive Impairment Research (10 papers), Alzheimer's disease research and treatments (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). Wenjun Zhou is often cited by papers focused on Dementia and Cognitive Impairment Research (10 papers), Alzheimer's disease research and treatments (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). Wenjun Zhou collaborates with scholars based in China, United States and Czechia. Wenjun Zhou's co-authors include Nathanael S. Gray, Pasi A. Jänne, Dalia Ercan, Kwok‐Kin Wong, Lucian R. Chirieac, John R. Engen, Robert F. Padera, Cai‐Hong Yun, Michael J. Eck and Roxana E. Iacob and has published in prestigious journals such as Nature, Neurology and Cancer Research.

In The Last Decade

Wenjun Zhou

51 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

2009 785 citations Wenjun Zhou, Dalia Ercan et al. Nature profile →

Peers

Wenjun Zhou

MB

PRM

ONCOL

IMMUN

OC

Uwe Haberkorn Germany

József Tóvári Hungary

Julie L. Boerner United States

Monique B. Nilsson United States

Elena Di Gennaro Italy

Zhaohui Jin United States

Tadaaki Yamada Japan

Bo Wei China

Soumitro Pal United States

Harald Gschaidmeier Germany

Uwe Haberkorn Germany

Wenjun Zhou

607 ×0.7

MB

450 ×0.6

PRM

592 ×0.7

ONCOL

136 ×0.6

IMMUN

63 ×0.3

OC

Citations per year, relative to Wenjun Zhou Wenjun Zhou (= 1×) peers Uwe Haberkorn

Countries citing papers authored by Wenjun Zhou

Since Specialization

Citations

This map shows the geographic impact of Wenjun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Zhou more than expected).

Fields of papers citing papers by Wenjun Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Zhou. The network helps show where Wenjun Zhou may publish in the future.

Co-authorship network of co-authors of Wenjun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Zhou. A scholar is included among the top collaborators of Wenjun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Zhou. Wenjun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wang, Hanming, et al.. (2025). Application of Chinese Medicine in Treatment of Ulcerative Colitis and Elucidation of Relevant Mechanisms. Chinese Journal of Integrative Medicine.

2.

Wei, Shuang, Wenjun Zhou, Han Young Yu, et al.. (2025). Prediction of Metabolic Dysfunction–Associated Steatotic Liver Disease via Advanced Machine Learning Among Chinese Han Population. Obesity Surgery. 35(10). 4192–4204.

3.

Wang, Xiwu, et al.. (2024). Characterizing the clinical heterogeneity of early symptomatic Alzheimer’s disease: a data-driven machine learning approach. Frontiers in Aging Neuroscience. 16. 1410544–1410544. 1 indexed citations

4.

Liu, Shuang, Weiyong Wang, Huiyu Liu, et al.. (2024). Berberine promotes primordial follicle activation and increases ovulated oocyte quantity in aged mice. Molecular Medicine. 30(1). 251–251. 1 indexed citations

5.

Wang, Xiwu, et al.. (2023). Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach. Alzheimer s Research & Therapy. 15(1). 57–57. 15 indexed citations

6.

Zhou, Wenjun, et al.. (2022). Recent advances in lean NAFLD. Biomedicine & Pharmacotherapy. 153. 113331–113331. 65 indexed citations

7.

Liu, Yujing, et al.. (2022). Secondary Bile Acids and Tumorigenesis in Colorectal Cancer. Frontiers in Oncology. 12. 813745–813745. 62 indexed citations

8.

Zhou, Wenjun, et al.. (2022). Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer. International Immunopharmacology. 109. 108798–108798. 8 indexed citations

9.

Chen, Yuxin, Qiu-Yue Han, Wenjun Zhou, et al.. (2021). Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer. Frontiers in Immunology. 12. 679090–679090. 30 indexed citations

10.

Li, Chunlin, et al.. (2021). Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway. Biomedicine & Pharmacotherapy. 139. 111587–111587. 30 indexed citations

11.

Dai, Liang, Wenjun Zhou, Linda L. D. Zhong, Xu-Dong Tang, & Guang Ji. (2020). Chinese medicine formulas for nonalcoholic fatty liver disease: Overview of systematic reviews. World Journal of Clinical Cases. 9(1). 102–117. 3 indexed citations

12.

Li, Qiong, Meng Li, Fenghua Li, et al.. (2020). Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. Journal of Ethnopharmacology. 258. 112896–112896. 29 indexed citations

13.

Wang, Xiwu, et al.. (2019). The Relationship Between Hippocampal Volumes and Delayed Recall Is Modified by APOE ε4 in Mild Cognitive Impairment. Frontiers in Aging Neuroscience. 11. 36–36. 9 indexed citations

14.

Wang, Zhaowei, Wenjun Zhou, Bo Zhou, & Jie Zhang. (2018). Association of vascular endothelial growth factor levels in CSF and cerebral glucose metabolism across the Alzheimer’s disease spectrum. Neuroscience Letters. 687. 276–279. 8 indexed citations

15.

Lin, Aifen, Xia Zhang, Ruili Zhang, et al.. (2018). Clinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients. Frontiers in Oncology. 8. 361–361. 21 indexed citations

16.

Zhou, Wenjun, et al.. (2017). Plasma neurofilament light chain levels in Alzheimer’s disease. Neuroscience Letters. 650. 60–64. 75 indexed citations

17.

Zhang, Jie, et al.. (2017). Risk factors for amyloid positivity in older people reporting significant memory concern. Comprehensive Psychiatry. 80. 126–131. 10 indexed citations

18.

Weisberg, Ellen, Hwan Geun Choi, Rosemary Barrett, et al.. (2010). Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors. Molecular Cancer Therapeutics. 9(9). 2468–2477. 12 indexed citations

19.

Zhou, Wenjun, Dalia Ercan, Liang Chen, et al.. (2009). Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature. 462(7276). 1070–1074. 785 indexed citations breakdown →

20.

McDermott, Ultan, A. John Iafrate, Nathanael S. Gray, et al.. (2008). Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors. Cancer Research. 68(9). 3389–3395. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact